• IntelliPlex™ Lung Cancer Panel - cfDNA


    The IntelliPlex™ Lung Cancer Panel - cfDNA is a qualitative molecular assay for the detection of mutations that are clinically actionable for targeted therapy selection in non-small cell lung cancer (NSCLC). The assay detects 55 DNA mutations in the KRAS, NRAS, PIK3CA, BRAF, EGFR, HER2, AKT1, MEK1 genes using cell-free DNA derived from plasma of patients with NSCLC.

     

    ORDER INQUIRY

Single-well-multiplex

detection of 55 DNA mutations

Non-invasive for the patients

(liquid biopsy specimen)

High sensitivity 
(LoD: 0.1~2.32 %)

Low DNA sample input 

(10ng)

< 3.5 hrs turnaround time

(sample preparation excluded)

High  throughput
(Up to 94 samples per run)

Specimen Requirements

With the IntelliPlex system, low DNA sample input is made possible to perform the testing 
  • 10 ng DNA extracted from plasma

Registration Status

CE IVD

Package Size

24 rxns

File Download

 

Order Information

Catalog No.
Product Name
Category
Unit Size
82030
IntelliPlex Lung Cancer Panel - cfDNA
ASSAY KIT
1 kit  (​24 rxns)
80033
IntelliPlex 1000  πCode Processor
INSTRUMENT
1 unit
80000
PlexBio 100 Fluorescent Analyzer
INSTRUMENT
1 unit
​​80002
Computer
INSTRUMENT
1 unit
​​80050/80051
​DeXipher RUO/MD
SOFTWARE
​1 set

 

Related Products

Catalog No.
Product Name
 
 
82006
IntelliPlex™ EGFR Mutation Kit
 
 
82022
IntelliPlex™ KRAS Mutation Plus Kit
 
 
82004
IntelliPlex™ BRAF V600 Mutation Kit
 
 
​​82020
​IntelliPlex™ NRAS Mutation Kit
 
 
​​82021
​IntelliPlex™ PIK3CA Mutation Kit
 
 
82023
IntelliPlex™ ALK Rearrangement Kit
 
 
​​82024
​IntelliPlex™ ROS1 Rearrangement Kit
 
 
​​82025
IntelliPlex™ RET/NTRK1 Rearrangement Kit
 
 
82028
IntelliPlex™ Lung Cancer Panel
 
 
​​82031
IntelliPlex™ Lung Cancer Panel - cfRNA